دورية أكاديمية

PENTRAXIN 3 LEVELS CORRELATE WELL WITH DISEASE SEVERITY AT ADMISSION IN COVID-19 PATIENTS.

التفاصيل البيبلوغرافية
العنوان: PENTRAXIN 3 LEVELS CORRELATE WELL WITH DISEASE SEVERITY AT ADMISSION IN COVID-19 PATIENTS.
المؤلفون: Işık ME; University of Health Sciences, Koşuyolu High Specialization Research and Training Hospital, Department of Infectious Diseases, Istanbul, Turkey., Korkusuz R; University of Health Sciences, Bakırköy Dr. Sadi Konuk Research and Training Hospital, Department of Infectious Diseases, Istanbul, Turkey., Şahingöz GE; University of Health Sciences, Bakırköy Dr. Sadi Konuk Research and Training Hospital, Department of Internal Medicine, Istanbul, Turkey., Işık AC; University of Health Sciences, Kartal Dr. Lütfi Kırdar City Hospital, Department of Internal Medicine, Istanbul, Turkey., Karagöz A; University of Health Sciences, Koşuyolu High Specialization Research and Training Hospital, Department of Cardiology, Istanbul, Turkey., Işıksaçan N; University of Health Sciences, Bakırköy Dr. Sadi Konuk Research and Training Hospital, Department of Biochemistry, Istanbul, Turkey., Taş SK; University of Health Sciences, Department of Immunology, Istanbul, Turkey., Yaşar KK; University of Health Sciences, Bakırköy Dr. Sadi Konuk Research and Training Hospital, Department of Infectious Diseases, Istanbul, Turkey.
المصدر: Acta clinica Croatica [Acta Clin Croat] 2022 Aug; Vol. 61 (2), pp. 303-310.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Sestre Milosrdnice University Hospital, Institute for Clinical Medical Research Country of Publication: Croatia NLM ID: 9425483 Publication Model: Print Cited Medium: Internet ISSN: 1333-9451 (Electronic) Linking ISSN: 03539466 NLM ISO Abbreviation: Acta Clin Croat Subsets: MEDLINE
أسماء مطبوعة: Publication: Sept. 1995- : Zagreb : Sestre Milosrdnice University Hospital, Institute for Clinical Medical Research,
Original Publication: Zagreb : Klinička bolnica "Sestre milosrdnice" : Institut za kliničko-medicinska istrazivanja u Zagrebu, 1991-
مواضيع طبية MeSH: Endothelial Cells* , COVID-19*, Humans ; Biomarkers ; SARS-CoV-2 ; C-Reactive Protein ; Patient Acuity
مستخلص: Pentraxin 3 (PTX3), a long pentraxin, is not only released from dendritic cells and neutrophils but also from epithelial and endothelial cells such as alveolar epithelium. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) initially activates the innate immune system, causing a complex immune response. Clinical and experimental studies suggest that PTX3, a locally and systemically secreted marker, can be used as a predictor of the severity and mortality in respiratory infections. In the current study, serum PTX3 levels in patients hospitalized with COVID-19 were found to be significantly increased at admission and showed significant association with the disease severity.
References: Nat Immunol. 2021 Jan;22(1):19-24. (PMID: 33208929)
J Infect. 2021 Apr;82(4):84-123. (PMID: 33147434)
Front Immunol. 2019 Dec 03;10:2817. (PMID: 31849985)
Acta Clin Croat. 2021 Mar;60(1):103-114. (PMID: 34588729)
Immunol Rev. 2009 Jan;227(1):75-86. (PMID: 19120477)
Clin Immunol. 2020 Jun;215:108448. (PMID: 32353634)
Medicine (Baltimore). 2020 Apr;99(14):e19532. (PMID: 32243370)
Lancet Respir Med. 2020 Jun;8(6):544-546. (PMID: 32380023)
J Clin Immunol. 2008 Jan;28(1):1-13. (PMID: 17828584)
Front Immunol. 2019 Apr 12;10:794. (PMID: 31031772)
Acta Clin Croat. 2020 Dec;59(4):740-744. (PMID: 34285445)
فهرسة مساهمة: Keywords: C-reactive protein; COVID-19; Innate immunity; Pentraxin 3; SARS-CoV-2
المشرفين على المادة: 148591-49-5 (PTX3 protein)
0 (Biomarkers)
9007-41-4 (C-Reactive Protein)
تواريخ الأحداث: Date Created: 20230223 Date Completed: 20230227 Latest Revision: 20230227
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9934037
DOI: 10.20471/acc.2022.61.02.17
PMID: 36818928
قاعدة البيانات: MEDLINE
الوصف
تدمد:1333-9451
DOI:10.20471/acc.2022.61.02.17